Head to Head Review: Sonova (OTCMKTS:SONVY) and Integer (NYSE:ITGR)

Integer (NYSE:ITGR) and Sonova (OTCMKTS:SONVY) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, analyst recommendations and risk.

Risk & Volatility

Integer has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, Sonova has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500.

Earnings and Valuation

This table compares Integer and Sonova”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.67 billion	2.62	$90.65 million	$2.89	45.13
Sonova	$3.80 billion	5.86	$678.65 million	N/A	N/A

Sonova has higher revenue and earnings than Integer.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Integer and Sonova, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0	1	6	0	2.86
Sonova	0	1	0	0	2.00

Integer presently has a consensus target price of $138.71, indicating a potential upside of 6.36%. Given Integer’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Integer is more favorable than Sonova.

Institutional and Insider Ownership

99.3% of Integer shares are held by institutional investors. Comparatively, 0.0% of Sonova shares are held by institutional investors. 2.0% of Integer shares are held by company insiders. Comparatively, 0.0% of Sonova shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Integer and Sonova’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Integer	6.31%	11.48%	5.79%
Sonova	N/A	N/A	N/A

Summary

Integer beats Sonova on 8 of the 12 factors compared between the two stocks.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

About Sonova

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.